ID   VSTM1_HUMAN             Reviewed;         236 AA.
AC   Q6UX27; B6A8C6; D2DJS3; D2DJS4; Q496B6; Q496B7;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-APR-2021, entry version 128.
DE   RecName: Full=V-set and transmembrane domain-containing protein 1;
DE   AltName: Full=Signal inhibitory receptor on leukocytes-1;
DE            Short=SIRL-1;
DE   Flags: Precursor;
GN   Name=VSTM1; ORFNames=UNQ3033/PRO9835;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION (ISOFORM 2),
RP   SUBCELLULAR LOCATION (ISOFORM 2), AND VARIANT GLY-163.
RC   TISSUE=Granulocyte, and Spleen;
RX   PubMed=22960280; DOI=10.1016/j.cellimm.2012.07.009;
RA   Guo X., Zhang Y., Wang P., Li T., Fu W., Mo X., Shi T., Zhang Z., Chen Y.,
RA   Ma D., Han W.;
RT   "VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and
RT   activation of Th17 cells.";
RL   Cell. Immunol. 278:136-142(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION (ISOFORM 1), ITIM MOTIF,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Peripheral blood monocyte;
RX   PubMed=20375307; DOI=10.4049/jimmunol.0902039;
RA   Steevels T.A., Lebbink R.J., Westerlaken G.H., Coffer P.J., Meyaard L.;
RT   "Signal inhibitory receptor on leukocytes-1 is a novel functional
RT   inhibitory immune receptor expressed on human phagocytes.";
RL   J. Immunol. 184:4741-4748(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-163.
RC   TISSUE=Bone marrow;
RA   Barrow A.D., de Bono B., Trowsdale J.;
RT   "OSCAR-like transcript-1 (OLT-1) mRNA.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-163.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 17-31.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
CC   -!- FUNCTION: [Isoform 2]: Behaves as a cytokine, promoting IL17A secretion
CC       by CD4+ T-cells, and differentiation and activation of IL17 producing
CC       helper T-cells (TH17).
CC   -!- FUNCTION: [Isoform 1]: Inhibitory immune receptor involved in the
CC       regulation of phagocytes.
CC   -!- INTERACTION:
CC       Q6UX27-3; Q86Y34: ADGRG3; NbExp=3; IntAct=EBI-12190699, EBI-17979264;
CC       Q6UX27-3; Q8WW43: APH1B; NbExp=3; IntAct=EBI-12190699, EBI-2606497;
CC       Q6UX27-3; Q13520: AQP6; NbExp=3; IntAct=EBI-12190699, EBI-13059134;
CC       Q6UX27-3; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-12190699, EBI-11343438;
CC       Q6UX27-3; P19397: CD53; NbExp=3; IntAct=EBI-12190699, EBI-6657396;
CC       Q6UX27-3; O95471: CLDN7; NbExp=3; IntAct=EBI-12190699, EBI-740744;
CC       Q6UX27-3; O95484: CLDN9; NbExp=3; IntAct=EBI-12190699, EBI-18341636;
CC       Q6UX27-3; Q8IUN9: CLEC10A; NbExp=3; IntAct=EBI-12190699, EBI-2873246;
CC       Q6UX27-3; O75208: COQ9; NbExp=3; IntAct=EBI-12190699, EBI-724524;
CC       Q6UX27-3; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-12190699, EBI-781551;
CC       Q6UX27-3; Q969F0: FATE1; NbExp=3; IntAct=EBI-12190699, EBI-743099;
CC       Q6UX27-3; Q9UK22: FBXO2; NbExp=3; IntAct=EBI-12190699, EBI-4287196;
CC       Q6UX27-3; P12314: FCGR1A; NbExp=3; IntAct=EBI-12190699, EBI-2869867;
CC       Q6UX27-3; Q8TBE3: FNDC9; NbExp=3; IntAct=EBI-12190699, EBI-12142257;
CC       Q6UX27-3; O95377: GJB5; NbExp=3; IntAct=EBI-12190699, EBI-3909454;
CC       Q6UX27-3; Q8NBJ4: GOLM1; NbExp=3; IntAct=EBI-12190699, EBI-712073;
CC       Q6UX27-3; Q8TED1: GPX8; NbExp=3; IntAct=EBI-12190699, EBI-11721746;
CC       Q6UX27-3; Q9UBK5: HCST; NbExp=3; IntAct=EBI-12190699, EBI-2801937;
CC       Q6UX27-3; P48051: KCNJ6; NbExp=3; IntAct=EBI-12190699, EBI-12017638;
CC       Q6UX27-3; P11279: LAMP1; NbExp=3; IntAct=EBI-12190699, EBI-2805407;
CC       Q6UX27-3; Q9HCJ2: LRRC4C; NbExp=3; IntAct=EBI-12190699, EBI-3925442;
CC       Q6UX27-3; Q9H8J5: MANSC1; NbExp=3; IntAct=EBI-12190699, EBI-2830042;
CC       Q6UX27-3; Q5TF39: MFSD4B; NbExp=3; IntAct=EBI-12190699, EBI-11922631;
CC       Q6UX27-3; Q6IN84: MRM1; NbExp=3; IntAct=EBI-12190699, EBI-5454865;
CC       Q6UX27-3; O43688: PLPP2; NbExp=3; IntAct=EBI-12190699, EBI-722017;
CC       Q6UX27-3; Q9H169-2: STMN4; NbExp=3; IntAct=EBI-12190699, EBI-20117546;
CC       Q6UX27-3; Q9NWD8: TMEM248; NbExp=3; IntAct=EBI-12190699, EBI-10314986;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Membrane {ECO:0000305}; Single-pass
CC       membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted
CC       {ECO:0000269|PubMed:22960280}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UX27-1; Sequence=Displayed;
CC       Name=2; Synonyms=VSTM1-v2;
CC         IsoId=Q6UX27-2; Sequence=VSP_022381;
CC       Name=3;
CC         IsoId=Q6UX27-3; Sequence=VSP_022382, VSP_022383;
CC   -!- TISSUE SPECIFICITY: Expressed on myeloid (neutrophils, eosinophils and
CC       monocytes) but not on lymphoid cells. {ECO:0000269|PubMed:20375307}.
CC   -!- DOMAIN: Contains 2 copies of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC       Both motives are required for full inhibition of FCER1A-mediated
CC       degranulation.
CC   -!- PTM: Isoform 2 is N-glycosylated.
CC   -!- MISCELLANEOUS: [Isoform 2]: Mainly detected in immune tissues and
CC       cells. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ584316; ACU00108.1; -; mRNA.
DR   EMBL; FJ584317; ACU00109.1; -; mRNA.
DR   EMBL; FJ584318; ACU00110.1; -; mRNA.
DR   EMBL; FN398145; CAZ61324.1; -; mRNA.
DR   EMBL; DQ479397; ABF19807.1; -; mRNA.
DR   EMBL; AY358542; AAQ88906.1; -; mRNA.
DR   EMBL; AC012314; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC100942; AAI00943.1; -; mRNA.
DR   EMBL; BC100943; AAI00944.1; -; mRNA.
DR   CCDS; CCDS12872.1; -. [Q6UX27-1]
DR   CCDS; CCDS74442.1; -. [Q6UX27-2]
DR   RefSeq; NP_001275720.1; NM_001288791.1.
DR   RefSeq; NP_001275721.1; NM_001288792.1. [Q6UX27-2]
DR   RefSeq; NP_001275722.1; NM_001288793.1.
DR   RefSeq; NP_940883.2; NM_198481.3. [Q6UX27-1]
DR   RefSeq; XP_016882155.1; XM_017026666.1. [Q6UX27-3]
DR   SMR; Q6UX27; -.
DR   BioGRID; 129868; 40.
DR   IntAct; Q6UX27; 27.
DR   STRING; 9606.ENSP00000343366; -.
DR   GlyGen; Q6UX27; 2 sites.
DR   BioMuta; VSTM1; -.
DR   DMDM; 296452860; -.
DR   MassIVE; Q6UX27; -.
DR   PaxDb; Q6UX27; -.
DR   PeptideAtlas; Q6UX27; -.
DR   PRIDE; Q6UX27; -.
DR   ProteomicsDB; 67552; -. [Q6UX27-1]
DR   ProteomicsDB; 67553; -. [Q6UX27-2]
DR   ProteomicsDB; 67554; -. [Q6UX27-3]
DR   Antibodypedia; 71979; 27 antibodies.
DR   Ensembl; ENST00000338372; ENSP00000343366; ENSG00000189068. [Q6UX27-1]
DR   Ensembl; ENST00000376626; ENSP00000365813; ENSG00000189068. [Q6UX27-2]
DR   Ensembl; ENST00000447872; ENSP00000401926; ENSG00000189068. [Q6UX27-3]
DR   Ensembl; ENST00000610629; ENSP00000482197; ENSG00000274953. [Q6UX27-1]
DR   Ensembl; ENST00000610794; ENSP00000478582; ENSG00000276159. [Q6UX27-1]
DR   Ensembl; ENST00000610804; ENSP00000480533; ENSG00000274887. [Q6UX27-1]
DR   Ensembl; ENST00000611293; ENSP00000482555; ENSG00000275330. [Q6UX27-1]
DR   Ensembl; ENST00000612105; ENSP00000483412; ENSG00000275577. [Q6UX27-1]
DR   Ensembl; ENST00000612436; ENSP00000482985; ENSG00000276066. [Q6UX27-1]
DR   Ensembl; ENST00000612864; ENSP00000481977; ENSG00000275962. [Q6UX27-3]
DR   Ensembl; ENST00000613042; ENSP00000479748; ENSG00000275577. [Q6UX27-2]
DR   Ensembl; ENST00000615235; ENSP00000479198; ENSG00000277607. [Q6UX27-2]
DR   Ensembl; ENST00000615508; ENSP00000484886; ENSG00000276066. [Q6UX27-2]
DR   Ensembl; ENST00000616717; ENSP00000480383; ENSG00000274953. [Q6UX27-2]
DR   Ensembl; ENST00000617115; ENSP00000481140; ENSG00000275330. [Q6UX27-2]
DR   Ensembl; ENST00000617281; ENSP00000480547; ENSG00000277607. [Q6UX27-1]
DR   Ensembl; ENST00000617776; ENSP00000484699; ENSG00000275962. [Q6UX27-2]
DR   Ensembl; ENST00000617862; ENSP00000484844; ENSG00000276363. [Q6UX27-1]
DR   Ensembl; ENST00000619024; ENSP00000483411; ENSG00000276159. [Q6UX27-2]
DR   Ensembl; ENST00000619921; ENSP00000483797; ENSG00000276363. [Q6UX27-2]
DR   Ensembl; ENST00000620474; ENSP00000484806; ENSG00000275962. [Q6UX27-1]
DR   Ensembl; ENST00000622762; ENSP00000483104; ENSG00000274887. [Q6UX27-2]
DR   GeneID; 284415; -.
DR   KEGG; hsa:284415; -.
DR   UCSC; uc002qcw.5; human. [Q6UX27-1]
DR   CTD; 284415; -.
DR   DisGeNET; 284415; -.
DR   GeneCards; VSTM1; -.
DR   HGNC; HGNC:29455; VSTM1.
DR   HPA; ENSG00000189068; Group enriched (blood, bone marrow).
DR   neXtProt; NX_Q6UX27; -.
DR   OpenTargets; ENSG00000189068; -.
DR   PharmGKB; PA147357166; -.
DR   VEuPathDB; HostDB:ENSG00000189068.9; -.
DR   eggNOG; ENOG502SXQ3; Eukaryota.
DR   GeneTree; ENSGT00980000198504; -.
DR   HOGENOM; CLU_103389_0_0_1; -.
DR   InParanoid; Q6UX27; -.
DR   OMA; TSHSEFP; -.
DR   OrthoDB; 1327293at2759; -.
DR   PhylomeDB; Q6UX27; -.
DR   TreeFam; TF336644; -.
DR   PathwayCommons; Q6UX27; -.
DR   BioGRID-ORCS; 284415; 4 hits in 975 CRISPR screens.
DR   ChiTaRS; VSTM1; human.
DR   GenomeRNAi; 284415; -.
DR   Pharos; Q6UX27; Tbio.
DR   PRO; PR:Q6UX27; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q6UX27; protein.
DR   Bgee; ENSG00000189068; Expressed in bone marrow and 91 other tissues.
DR   ExpressionAtlas; Q6UX27; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytokine; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Immunity; Immunoglobulin domain; Membrane;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           17..236
FT                   /note="V-set and transmembrane domain-containing protein 1"
FT                   /id="PRO_0000272269"
FT   TOPO_DOM        17..135
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..156
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        157..236
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..114
FT                   /note="Ig-like V-type"
FT   MOTIF           204..209
FT                   /note="ITIM motif 1"
FT   MOTIF           229..234
FT                   /note="ITIM motif 2"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..96
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         132..163
FT                   /note="DTRTIFVAIFSCISILLLFLSVFIIYRCSQHS -> G (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:22960280"
FT                   /id="VSP_022381"
FT   VAR_SEQ         164..174
FT                   /note="SSSEESTKRTS -> ELRERKGREGE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022382"
FT   VAR_SEQ         175..236
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_022383"
FT   VARIANT         163
FT                   /note="S -> G (in dbSNP:rs2433724)"
FT                   /evidence="ECO:0000269|PubMed:12975309,
FT                   ECO:0000269|PubMed:22960280, ECO:0000269|Ref.3"
FT                   /id="VAR_030034"
SQ   SEQUENCE   236 AA;  26109 MW;  508E7881ADF6E1A5 CRC64;
     MTAEFLSLLC LGLCLGYEDE KKNEKPPKPS LHAWPSSVVE AESNVTLKCQ AHSQNVTFVL
     RKVNDSGYKQ EQSSAENEAE FPFTDLKPKD AGRYFCAYKT TASHEWSESS EHLQLVVTDK
     HDELEAPSMK TDTRTIFVAI FSCISILLLF LSVFIIYRCS QHSSSSEEST KRTSHSKLPE
     QEAAEADLSN MERVSLSTAD PQGVTYAELS TSALSEAASD TTQEPPGSHE YAALKV
//
